EAAT2 impairment has been associated with Alzheimer's disease (AD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). This evidence concerns the gene SLC1A2 and early-onset autosomal dominant Alzheimer disease.